About Proto Axiom
Australia produces world leading intellectual property in drug development and medical equipment, yet captures virtually none of the downstream commercialisation and job multipliers. This is in part due to underdeveloped domestic preclinical expertise. Proto Axiom on shores this capacity, keeping Australian IP in Australia.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, Healthcare, Real Estate (+1 more)
Investor Type
Incubator
Investment Focus
Focus Areas